Sio Gene Therapies Inc.

SIOX · NASDAQ
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Operating Activities
Net Income-$4-$3-$8-$13
Dep. & Amort.$0-$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0-$0-$3
Change in WC-$1-$3-$0-$2
Other Non-Cash-$0$1-$0-$0
Operating Cash Flow-$5-$5-$9-$18
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$5-$5-$9-$17
Supplemental Information
Beg. Cash$51$56$65$82
End Cash$46$51$56$65
Free Cash Flow-$5-$5-$9-$18
Sio Gene Therapies Inc. (SIOX) Financial Statements & Key Stats | AlphaPilot